Advances in the therapy of Alzheimer's disease: targeting amyloid beta and tau and perspectives for the future

导出原文传递

翻译打印收藏纠错

作者： Hampel, Harald ^[1] ; Schneider, Lon S. ^[2] ; Giacobini, Ezio ^[3] ; Kivipelto, Miia ^[4] ; Sindi, Shireen ^[5] ; Dubois, Bruno ^[6] ; Broich, Karl ^[7] ; Nistico, Robert ^[8] ; Aisen, Paul S. ; Lista, Simone

作者单位： AXA Res Fund, Paris, France ^[1] Univ Paris 06, Univ Paris 04, IM2A, Paris, France ^[2] Univ So Calif, Keck Sch Med, Los Angeles, CA 90033 USA ^[3] Univ Geneva, Fac Med, Dept Internal Med Rehabil & Geriatr, Geneva, Switzerland ^[4] Karolinska Inst, Ctr Alzheimer Res, Stockholm, Sweden ^[5] Univ Roma La Sapienza, Dept Physiol & Pharmacol, I-00185 Rome, Italy ^[6] Univ Calif San Diego, Dept Neurosci, San Diego, CA 92103 USA ^[7] Fed Inst Drugs & Med Devices BfArM, Bonn, Germany ^[8]

关键词 Alzheimer's disease amyloid beta immunotherapy bapineuzumab biological markers clinical trials prevention randomized controlled trials center dot systems biology solanezumab tau immunotherapy

发布时间 2015-04-11

翻译满意度评价：

准确一般字义偏差语意偏离译文作用小提交